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Abstract
Decision makers, such as doctors and judges,
make crucial decisions such as recommending
treatments to patients, and granting bails to de-
fendants on a daily basis. Such decisions typi-
cally involve weighting the potential benefits of
taking an action against the costs involved. In
this work, we aim to automate this task of learn-
ing cost-effective, interpretable and actionable
treatment regimes. We formulate this as a prob-
lem of learning a decision list – a sequence of
if-then-else rules – which maps characteristics of
subjects (eg., diagnostic test results of patients)
to treatments. We propose a novel objective to
construct a decision list which maximizes out-
comes for the population, and minimizes overall
costs. We model the problem of learning such
a list as a Markov Decision Process (MDP) and
employ a variant of the Upper Confidence Bound
for Trees (UCT) strategy which leverages cus-
tomized checks for pruning the search space ef-
fectively. Experimental results on real world ob-
servational data capturing judicial bail decisions
and treatment recommendations for asthma pa-
tients demonstrate the effectiveness of our ap-
proach.
1 Introduction
Medical and judicial decisions can be complex: they in-
volve careful assessment of the subject’s condition, analyz-
ing the costs associated with the possible actions, and the
nature of the consequent outcomes. Further, there might
be costs associated with the assessment of the subject’s
condition itself (e.g., physical pain endured during medi-
cal tests, monetary costs etc.). For instance, a doctor first
If Spiro-Test=Pos and Prev-Asthma=Yes and Cough=High then C
Else if Spiro-Test=Pos and Prev-Asthma =No then Q
Else if Short-Breath =Yes and Gender=F and Age≥ 40 and Prev-Asthma=Yes then C
Else if Peak-Flow=Yes and Prev-RespIssue=No and Wheezing =Yes, then Q
Else if Chest-Pain=Yes and Prev-RespIssue =Yes and Methacholine =Pos then C
Else Q
Figure 1: Regime for treatment recommendations for
asthma patients output by our framework; Q refers to
milder forms of treatment used for quick-relief, and C
corresponds to more intense treatments such as controller
drugs (C is higher cost than Q); Attributes in blue are least
expensive.
diagnoses the patient’s condition by studying the patient’s
medical history and ordering a set of relevant tests that are
crucial to the diagnosis. In doing so, she also factors in the
physical, mental and monetary costs incurred due to each
of these tests. Based on the test results, she carefully de-
liberates various treatment options, analyzes the potential
side-effects as well as the effectiveness of each of these op-
tions. Analogously, a judge deciding if a defendant should
be granted bail studies the criminal records of the defen-
dant, and enquires for additional information (e.g., defen-
dant’s personal life or economic status) if needed. She then
recommends a course of action that trades off the risk with
granting bail to the defendant (the defendant may commit
a new crime when out on bail) with the cost of denying bail
(adverse effects on defendant, or defendant’s family, cost
of jail to the county).
In practical situations, human decision makers often lever-
age personal experience to make decisions, without consid-
ering data, even if massive amounts of it exist for the prob-
lem at hand. There exist domains where machine learn-
ing models could potentially help – but they would need to
consider all three aspects discussed above: predictions of
counterfactuals, costs of gathering information, and costs
of treatments. Further, these models must be interpretable
in order to create any reasonable chance of a human deci-
sion maker actually using them. In this work, we address
the problem of learning such cost-effective, interpretable
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treatment regimes from observational data.
Prior research addresses various aspects of the problem at
hand in isolation. For instance, there exists a large body of
literature on estimating treatment effects [8, 24, 7], recom-
mending optimal treatments [1, 34, 9], and learning intel-
ligible models for prediction [19, 16, 21, 4]. However, an
effective solution for the problem at hand should ideally in-
corporate all of the aforementioned aspects. Furthermore,
existing solutions for learning treatment regimes neither ac-
count for the costs associated with gathering the required
information, nor the treatment costs. The goal of this work
is to propose a framework which jointly addresses all of the
aforementioned aspects.
We address the problem at hand by formulating it as a task
of learning a decision list that maps subject characteristics
to treatments (such as the one shown in Figure 1) such that
it: 1) maximizes the expectation of a pre-specified outcome
when used to assign treatments to a population of interest
2) minimizes costs associated with assessing subjects’ con-
ditions and 3) minimizes costs associated with the treat-
ments themselves. We choose decision lists to express the
treatment regimes because they are highly intelligible, and
therefore, readily employable by decision makers. We pro-
pose a novel objective function to learn a decision list op-
timized with respect to the criterion highlighted above. We
prove that the proposed objective is NP-hard by reducing
it to the weighted exact cover problem. We then optimize
this objective by modeling it as a Markov Decision Pro-
cess (MDP) and employing a variant of the Upper Con-
fidence Bound for Trees (UCT) strategy which leverages
customized checks for pruning the search space effectively.
We empirically evaluate the proposed framework on two
real world datasets: 1) judicial bail decisions 2) treatment
recommendations for asthma patients. Our results demon-
strate that the regimes output by our framework result in
improved outcomes compared to state-of-the-art baselines
at much lower costs. Further, the treatment regimes output
by our approach are less complex and require fewer diag-
nostic checks to determine the optimal treatment.
2 Related Work
Below, we provide an overview of related research
on learning treatment regimes, dynamic optimal treat-
ment regimes, subgroup analysis, and interpretable models.
Treatment Regimes. The problem of learning treat-
ment regimes has been extensively studied in the con-
text of medicine and health care. Along the lines of
[36], literature on treatment regimes can be categorized as:
regression-based methods and policy-search-based meth-
ods. Regression-based methods [28, 32, 29, 33, 40, 28, 26]
model the conditional distribution of the outcomes given
the treatment and characteristics of patients and choose the
treatment resulting in the best possible outcome for each in-
dividual. Policy-search-based methods search for a policy
(a function which assigns treatments to individuals) within
a pre-specified class of policies. The policy is chosen to
optimize the expected outcome across the population of
interest. Examples of such estimators include marginal
structural mean models [29], outcome weighted learn-
ing [39, 38], and robust marginal mean models [35, 36].
Very few of the aforementioned solutions [36, 25] produce
regimes which are intelligible. None of the aforementioned
approaches explicitly account for treatment costs and costs
associated with gathering information pertaining to patient
characteristics.
While most work on learning treatment regimes has been
done in the context of medicine, the same ideas apply to
policies in other fields. To the best of our knowledge, this
work is the first attempt in extending work on treatment
regimes to judicial bail decisions.
Dynamic Treatment Regimes. Recent research in person-
alized medicine has focused on developing dynamic treat-
ment regimes [15, 37, 34, 9]. The goal is to learn treat-
ment regimes that maximize outcomes for patients in a
given population by recommending a sequence of appro-
priate treatments over time, based on the state of the pa-
tient. There has been little attention paid to interpretability
in this literature (with the exception of [37]). None of the
prior solutions for this problem consider treatment costs or
costs associated with diagnosing a patient’s condition.
Subgroup Analysis. The goal of this line of research is
to find out whether there exist subgroups of individuals in
which a given treatment exhibits heterogeneous effects, and
if so, how the treatment effect varies across them. This
problem has been well studied [31, 10, 20, 3, 11]. However,
identifying subgroups with heterogeneous treatment effects
does not readily provide us with regimes.
Interpretable Models. A large body of machine learning
literature focused on developing interpretable models for
classification [19, 16, 21, 4] and clustering [12, 18, 17].
To this end, various classes of models such as decision
lists [19], decision sets [16], prototype (case) based mod-
els [4], and generalized additive models [21] were pro-
posed. These classes of models were not conceived to
model treatment effects. There has been recent work on
leveraging decision lists to describe estimated treatment
regimes [25, 14, 36]. These solutions do not account for the
treatment costs or costs involved in gathering patient char-
acteristics. They are also constructed using greedy meth-
ods, which causes issues with the quality of the models.
3 Our Framework
First, we formalize the notion of treatment regimes and dis-
cuss how to represent them as decision lists. We then pro-
pose an objective function for constructing cost-effective
treatment regimes.
3.1 Input Data and Cost Functions
Consider a dataset D = {(x1, a1, y1), (x2, a2, y2) · · ·
(xN , aN , yN )} comprised of N independent and identi-
cally distributed observations, each of which corresponds
to a subject (individual), potentially from an observational
study. Let xi =
[
x
(1)
i , x
(2)
i , · · ·x(p)i
]
∈ [V1,V2, · · · Vp] de-
note the characteristics of subject i. Vf denotes the set of
all possible values that can be assumed by a characteristic
f ∈ F = {1, 2, · · · p}. Each characteristic f ∈ F can ei-
ther be a binary, categorical or real valued variable. In the
medical setting, example characteristics include patient’s
age, BMI, gender, red blood cell count, glucose level etc.,
Let ai ∈ A = {1, 2, · · ·m} and yi ∈ R denote the treat-
ment assigned to subject i and the corresponding outcome
respectively. We assume that yi is defined such that higher
values indicate better outcomes. For example, the outcome
of a patient can be regarded as a wellness improvement
score that indicates the effectiveness of the assigned treat-
ment.
It can be much more expensive to determine certain sub-
ject characteristics compared to others. For instance, a
patient’s age can be easily retrieved either from previous
records or by asking the patient. On the other hand, de-
termining her glucose level requires more comprehensive
testing, and is therefore more expensive in terms of mon-
etary costs, time and effort required both from the patient
as well as the clinicians. We assume access to a function
d : F → R which returns the cost of determining any char-
acteristic in F . The cost associated with a given character-
istic f ∈ F is assumed to be the same for all the subjects
in the population, though the framework can be extended
to have patient-specific costs. Analogously, each treatment
a ∈ A incurs a cost and we assume access to a function
d′ : A → R which returns the cost associated with treat-
ment a ∈ A.
We now discuss the notion of a treatment regime formally,
and then introduce the class of models that we employ to
express such regimes.
3.2 Treatment Regimes
A treatment regime is a function which takes as input the
characteristics of any given subject x and maps them to an
appropriate treatment a ∈ A. As discussed, prior stud-
ies [30, 23] suggest that decision makers such as doctors
and judges who make high stake decisions are more likely
to trust, and, therefore employ models which are inter-
pretable and transparent. We thus employ decision lists to
express treatment regimes (see example in Figure 1). A de-
cision list is an ordered list of rules embedded within an if-
then-else structure. A treatment regime1 expressed as a de-
cision list pi is a sequence of L+1 rules [r1, r2, · · · , rL+1].
The last one, rL+1, is a default rule which applies to all
those subjects who do not satisfy any of the previous L
rules. Each rule rj (except the default rule) is a tuple
of the form (cj , aj) where aj ∈ A, and cj represents
a pattern which is a conjunction of one or more predi-
cates. Each predicate takes the form (f, o, v) where f ∈ F ,
o ∈ {=, 6=,≤,≥, <,>}, and v ∈ Vf denotes some value v
that can be assumed by the characteristic f . For instance,
“Age≥ 40 ∧Gender=Female” is an example of such a pat-
tern. A subject i is said to satisfy rule j if his/her character-
istics xi satisfy all the predicates in cj . Let us formally de-
note this using an indicator function, satisfy(xi, cj) which
returns a 1 if xi satisfies cj and 0 otherwise.
The rules in pi partition the dataset D into L + 1 groups:
{R1,R2 · · ·RL,Rdefault}. A group Rj , where j ∈
{1, 2, · · ·L}, is comprised of those subjects that satisfy cj
but do not satisfy any of c1, c2, · · · cj−1. This can be for-
mally written as:
Rj =
{
x ∈ [V1 · · · Vp] | satisfy(x, cj} ∧
j−1∧
t=1
¬ satisfy(x, ct)
}
.
(1)
The treatment assigned to each subject by pi is determined
by the group that he/she belongs to. For instance, if subject
i with characteristics xi belongs to group Rj induced by
pi i.e., xi ∈ Rj , then subject i will be assigned the corre-
sponding treatment aj under the regime pi. More formally,
pi(xi) =
L∑
l=1
al 1(xi ∈ Rl) + adefault 1(xi ∈ Rdefault) (2)
where 1 denotes an indicator function that returns 1 if the
condition within the brackets evaluates to true and 0 other-
wise. Thus, pi returns the treatment assigned to xi.
Similarly, the cost incurred when we assign a treatment to
the subject i (treatment cost) according to the regime pi is
given by:
φ(xi) = d′(pi(xi)) (3)
where the function d′, defined in Section 3.1., takes as input
a treatment a ∈ A and returns its cost.
We can also define the cost incurred in assessing the con-
dition of a subject i (assessment cost) as per the regime pi.
Note that a subject i belongs to the group Rj if and only
if the subject does not satisfy the conditions c1 · · · cj−1,
1We use the terms decision list and treatment regimes inter-
changeably from here on.
but satisfies the condition cj (Refer to Eqn. 1). To reach
this conclusion, all the characteristics present in the cor-
responding antecedents c1 · · · cj must have been measured
for subject i and evaluated against the appropriate predicate
conditions. This implies that the assessment cost incurred
for this subject i is the sum of the costs of all the character-
istics that appear in c1 · · · cj . IfNl denotes the set of all the
characteristics that appear in c1 · · · cl, the assessment cost
of the subject i as per the regime pi can be written as:
ψ(xi) =
L∑
l=1
[
1(xi ∈ Rl)×
(∑
e∈Nl
d(e)
)]
. (4)
3.3 Objective Function
We now formulate the objective function for learning a
cost-effective treatment regime. We first formalize the no-
tions of expected outcome, assessment, and treatment costs
of a treatment regime pi with respect to the dataset D.
Expected Outcome Recall that the treatment regime pi
assigns a subject i with characteristics xi to a treatment
pi(xi) (Equation 2). The quality of the regime pi is partly
determined by the expected outcome when all the subjects
inD are assigned treatments according to pi. The higher the
value of such an expected outcome, the better the quality of
the regime pi. There is, however, one caveat to computing
the value of this expected outcome – we only observe the
outcome yi resulting from assigning xi to ai in the data D,
and not any of the counterfactuals. If the regime pi, on the
other hand, assigns a different treatment a′ 6= ai to xi, we
cannot evaluate the policy on xi.
The solutions proposed to compute expected outcomes in
settings such as ours can be categorized as: adjustment
by regression modeling, adjustment by inverse propensity
score weighting, and doubly robust estimation. A de-
tailed treatment of each of these approaches is presented in
Lunceford et al. [22]. The success of regression based mod-
eling and inverse weighting depends heavily on the postu-
lated regression model and the postulated propensity score
model respectively. In either case, if the postulated models
are not identical to the true models, we have biased esti-
mates of the expected outcome. On the other hand, doubly
robust estimation combines the above approaches in such
a way that the estimated value of the expected outcome is
unbiased as long as one of the postulated models is identi-
cal to the true model. The doubly robust estimator for the
expected outcome of the regime pi, denoted by g1(pi), can
be written as:
g1(pi) =
1
N
N∑
i=1
∑
a∈A
o(i, a) where (5)
o(i, a) =[
1(ai = a)
ωˆ(xi, a)
(yi − yˆ(xi, a)) + yˆ(xi, a)
]
1(pi(xi) = a).
ωˆ(xi, a) denotes the probability that the subject iwith char-
acteristics xi is assigned to treatment a in the data D. ωˆ
represents the propensity score model. In practice, we fit
a multinomial logistic regression model on D to learn this
function. Our framework does not impose any constraints
on the functional form of ωˆ. Similarly, yˆ(xi, a) denotes
the predicted outcome obtained as a result of assigning a
subject characterized by xi to a treatment a. yˆ corresponds
to the outcome regression model and is learned in our ex-
periments by fitting a linear regression model on D prior
to optimizing for the treatment regimes. yˆ and ωˆ could be
modeled using any other method; this is an entirely sepa-
rate step from the algorithm discussed here.
Expected Assessment Cost Recall that there are assess-
ment costs associated with each subject. These costs are
governed by the characteristics that will be used in assess-
ing the subject’s condition and recommending a treatment.
The assessment cost of a subject i treated using regime pi
is given in Eqn. 4. The expected assessment cost across the
entire population can be computed as:
g2(pi) =
1
N
N∑
i=1
ψ(xi). (6)
It is important to ensure that our learning process favors
regimes with smaller values of expected assessment cost.
Keeping this cost low also ensures that the full decision list
is sparse, which assists with interpretability.
Expected Treatment Cost There is a cost associated
with assigning treatment to any given subject. The treat-
ment cost for a subject i who is assigned treatment using
regime pi is given in Eqn. 3. The expected treatment cost
across the entire population can be computed as:
g3(pi) =
1
N
N∑
i=1
φ(xi). (7)
The smaller the expected treatment cost of a regime, the
more desirable it is in practice. We present the complete
objective function below.
Complete Objective We assume access to the following
inputs: 1) the observational data D; 2) a set FP of fre-
quently occurring patterns in D. Recall that each pattern
corresponds to a conjunction of one or more predicates. An
example pattern is “Age≥ 40 ∧Gender=Female”. In prac-
tice, such patterns can be obtained by running a frequent
pattern mining algorithm such as Apriori [2] on the set D;
3) a set of all possible treatments A.
We define the set of all possible (pattern, treatment) tuples
as L = {(c, a)|c ∈ FP, a ∈ A} and C(L) as the set
of all possible combinations of L. An element in L can
be thought of as a rule in a decision list and an element
in C(L) can be thought of a list of rules in a decision list
(without the default rule). We then search over all elements
in the set C(L)×A to find a regime which maximizes the
expected outcome (Eqn. 5) while minimizing the expected
assessment (Eqn. 6), and treatment costs (Eqn. 7) all of
which are computed over D. Our objective function can be
formally written as:
arg max
pi∈C(L)×A
λ1g1(pi)− λ2g2(pi)− λ3g3(pi) (8)
where g1, g2, g3 are defined in Eqns. 5, 6, 7 respectively,
and λ1 and λ2 are non-negative weights that scale the rela-
tive influence of the terms in the objective.
Theorem 1 The objective function in Eqn. 9 is NP-hard.
(Please see appendix for details.)
Note that NP-hardness is a worst case categorization only;
with an efficient search procedure, it is practical to obtain a
good approximation on most reasonably-sized datasets.
3.4 Optimizing the Objective
We optimize our objective by modeling it as as a Markov
Decision Process (MDP) and then employing Upper Con-
fidence Bound on Trees (UCT) algorithm to find a treat-
ment regime which maximizes Eqn. 9. We also propose
and leverage customized checks for guiding the exploration
of the UCT algorithm and pruning the search space effec-
tively.
Markov Decision Process Formulation Our goal is to
find a sequence of rules which maximize the objective
function in Eqn. 9. To this end, we formulate a fully ob-
servable MDP such that the optimal policy of the posited
formulation provides a solution to our objective function.
A fully observable MDP is characterized by a tuple
(S,A,T,R) where S denotes the set of all possible states,
A denotes the set of all possible actions, T and R represent
the transition and reward functions respectively. Below we
define each of these in the context of our problem. Figure
2 shows a snapshot of the state space and transitions for a
small dataset.
State Space. Conceptually, each state in our state space
captures the effect of some partial or fully constructed de-
cision list. To illustrate, let us consider a partial decision
list with just one rule “if Age ≥ 40 ∧ Gender = Female,
then T1”. This partial list induces that: (i) all those subjects
that satisfy the condition of the rule are assigned treatment
T1, and (ii) Age and gender characteristics will be required
in determining treatments for all the subjects in the popula-
tion.
Age BMI T
0 0 0
0 0 0
0 0 0
Start State
Age BMI T
0 0 1
0 0 1
0 0 1
Terminal State
Age BMI T
0 1 2
0 1 2
0 1 0
Non-Terminal State
Age BMI T
22 High 1
43 High 2
38 Normal 1
Observational Data
MDP State Space and Transitions 
Figure 2: Sample Observational Data and the correspond-
ing Markov Decision Process Representation; T stands for
Treatment.
To capture such information, we represent a state s˜ ∈ S by
a list of tuples [(τ1(s˜), σ1(s˜)), · · · (τN (s˜), σN (s˜))] where
each tuple corresponds to a subject in D. τi(s˜) is a bi-
nary vector of length p defined such that τ (j)i (s˜) = 1 if
the characteristic j will be required for determining subject
i’s treatment, and 0 otherwise. Further, σi(s˜) captures the
treatment assigned to subject i. If no treatment has been
assigned to i, then σi(s˜) = 0.
Note that we have a single start state s˜0 which corresponds
to an empty decision list. τi(s˜0) is a vector of 0s, and
σi(s˜0) = 0 for all i in D indicating that no treatments have
been assigned to any subject, and no characteristics were
deemed as requirements for assigning treatments. Further-
more, a state s˜ is regarded as a terminal state if for all i,
σi(s˜) is non-zero indicating that treatments have been as-
signed to all the subjects.
Actions. Each action can take one of the following forms:
1) a rule r ∈ L, which is a tuple of the form (pattern,
treatment). Eg., (Age≥40 ∧ Gender=Female, T1). This
specifies that subjects who obey conditions in the pattern
are prescribed the treatment. Such action leads to a non-
terminal state. 2) a treatment a ∈ A, which corresponds to
the default rule, thus this action leads to a terminal state.
Transition and Reward Functions. We have a deterministic
transition function which ensures that taking an action a˜ =
(c˜, t˜) from state s˜ will always lead to the same state s˜′. Let
U denote the set of all those subjects i for which treatments
have already been assigned to be in state s˜ i.e., σi(s˜) 6= 0
and let U c denote the set of all those subjects who have not
been assigned treatment in the state s˜. Let U ′ denote the
set of all those subjects i which do not belong to the set U
and which satisfy the condition c˜ of action a˜. Let Q denote
the set of all those characteristics in F which are present
in the condition c˜ of action a˜. If action a˜ corresponds to a
default rule, then Q = ∅ and U ′ = U c. With this notation
in place, the new state s˜′ can be characterized as follows:
1) τ (j)i (s˜
′) = τ (j)i (s˜) and σi(s˜
′) = σi(s˜) for all i ∈ U ,
j ∈ F ; 2) τ (j)i (s˜′) = 1 for all i ∈ U c, j ∈ Q; 3) σi(s˜′) = t˜
for all i ∈ U ′.
Similarly, the immediate reward obtained when we reach s˜′
by taking a˜ = (c˜, t˜) from the state s˜ can be written as:
λ1
N
∑
i∈U ′
o(i, t˜)− λ2
N
∑
i∈Uc,j∈Q
d(j)− λ3
N
∑
i∈U ′
d′(t˜)
where o is defined in Eqn. 5, d and d′ are cost functions
for characteristics and treatments respectively (see Section
3.1).
UCT with Customized Pruning The basic idea behind
the Upper Confidence Bound on Trees (UCT) [13] algo-
rithm is to iteratively construct a search tree for some pre-
determined number of iterations. At the end of this proce-
dure, the best performing policy or sequence of actions is
returned as the output. Each node in the search tree corre-
sponds to a state in the MDP state space and the links in
the tree correspond to the actions. UCT employs the UCB-
1 metric [6] for navigating through the search space.
We employ a UCT-based algorithm for finding the optimal
policy of our MDP formulation, though we leverage cus-
tomized checks to further guide the exploration process and
prune the search space. Recall that each non-terminal state
in our state space corresponds to a partial decision list. We
exploit the fact that we can upper-bound the value of the ob-
jective for any given partial decision list. The upper bound
on the objective for any given non-terminal state s˜ can be
computed by approximating the reward as follows: 1) all
the subjects who have not been assigned treatments will
get the best possible treatments without incurring any treat-
ment cost 2) no additional assessments are required by any
subject (and hence no additional assessment costs levied)
in the population. The upper bound on the incremental re-
ward is thus:
upper bound(U c) = λ1
1
N
∑
i∈Uc
max
t
o(i, t).
During the execution of UCT procedure, whenever there is
a choice to be made about which action needs to be taken,
we employ checks based on the upper bound of the ob-
jective value of the resulting state. Consider a scenario in
which the UCT procedure is currently in state s˜ and needs
to choose an action. For each possible action a˜ (that does
not correspond to a default rule2) from state s˜, we deter-
mine the upper bound on the objective value of the result-
ing state s˜′. If this value is less than either the highest value
encountered previously for a complete rule list, or the ob-
jective value corresponding to the best default action from
the state s˜, then we block the action a˜ from the state s˜. This
state is provably suboptimal.
2We can compute exact values of objective function if the ac-
tion is a default rule because the corresponding decision list is
fully constructed.
4 Experimental Evaluation
Here, we discuss the detailed experimental evaluation of
our framework. First we analyze the outcomes obtained
and costs incurred when recommending treatments using
our approach. Then, we present an ablation study which
explores the contributions of each of the terms in our ob-
jective, followed by an analysis on real data.
Dataset Descriptions Our first dataset consists of infor-
mation pertaining to the bail decisions of about 86K defen-
dants (see Table 1). It captures information about various
defendant characteristics such as demographic attributes,
past criminal history, personal and health related informa-
tion for each of the 86K defendants. Further, the decisions
made by judges in each of these cases (release without/with
conditions) and the corresponding outcomes (e.g., if a de-
fendant committed another crime when out on bail) are also
available.
We assigned costs to characteristics, and treatments based
on discussions with subject matter experts. The character-
istics that were harder to obtain were assigned higher costs
compared to the ones that were readily available. Similarly,
the treatment that placed a higher burden on both the de-
fendant (release on condition) was assigned a higher cost.
When assigning scores to outcomes, undesirable scenarios
(e.g., violent crime when released on bail) received lower
scores.
Our second dataset (Refer Table 1) captures details of about
60K asthma patients [16]. For each of these 60K patients,
various attributes such as demographics, symptoms, past
health history, test results have been recorded. Each patient
in the dataset was prescribed either quick relief medications
or long term controller drugs. Further, the outcomes in the
form of time to the next asthma attack (after the treatment
began) were recorded. The longer this interval, the better
the outcome, and the higher the outcome score.
We assigned costs to characteristics, and treatments based
on the inconvenience (physical/mental/monetary) they
caused to patients.
Baselines We compared our framework to the following
state-of-the-art treatment recommendation approaches: 1)
Outcome Weighted Learning (OWL) [39] 2) Modified Co-
variate Approach (MCA) [32] 3) Interpretable and Parsi-
monious Treatment Regime Learning (IPTL) [36]. While
none of these approaches explicitly account for treatment
costs or costs required for gathering the subject character-
istics, MCA and IPTL minimize the number of character-
istics/covariates required for deciding the treatment of any
given subject. OWL, on the other hand, utilizes all the char-
acteristics available in the data when assigning treatments.
Bail Dataset Asthma Dataset
# of Data Points 86152 60048
Characteristics & Costs age, gender, previous offenses, prior arrests, age, gender, BMI, BP, short breath, temperature,
current charge, SSN (cost = 1) cough, chest pain, wheezing, past allergies, asthma history,
family history, has insurance (cost 1)
marital status, kids, owns house, pays rent peak flow test (cost = 2)
addresses in past years (cost = 2)
spirometry test (cost = 4)
mental illness, drug tests (cost = 6) methacholine test (cost = 6)
Treatments & Costs release on personal recognizance (cost = 20) quick relief (cost = 10)
release on conditions/bond (cost = 40) controller drugs (cost = 15)
Outcomes & Scores no risk (score = 100), failure to appear (score = 66) no asthma attack for≥ 4 months (score = 100)
non-violent crime (score = 33) no asthma attack for 2 months (score = 66)
violent crime (score = 0) no asthma attack for 1 month (score = 33)
asthma attack in less than 2 weeks (score = 0)
Table 1: Summary of datasets.
Experimental Setting The objective function that we
proposed in Eqn. 9 has three parameters λ1, λ2, and λ3.
These parameters could either be specified by an end-user
or learned using a validation set. We set aside 5% of each of
our datasets as a validation set to estimate these parameters.
We automatically searched the parameter space to find a set
of parameters that produced a decision list with the maxi-
mum average outcome on the validation set (discussed in
detail later) and satisfied some simple constraints such as:
1) average assessment cost≤ 4 on both the datasets 2) aver-
age treatment cost≤ 30 for the bail data; average treatment
cost ≤ 12 for the asthma data. We then used a coordinate
ascent strategy to search the parameter space and update
each parameter λj while holding the other two parameters
constant. The values of each of these parameters were cho-
sen via a binary search on the interval (0, 1000). We ran the
UCT procedure for our approach for 50K iterations. We
used both gaussian and linear kernels for OWL and em-
ployed the tuning strategy discussed in Zhao et. al. [39]. In
case of IPTL, we set the parameter that limits the number
of the rules in the treatment regime to 20. We evaluated
the performance of our model and other baselines using 10
fold cross validation.
4.1 Quantitative Evaluation
We analyzed the performance of our approach CITR (Cost-
effective, Interpretable Treatment Regimes) on various as-
pects such as outcomes obtained, costs incurred, and intel-
ligibility. We computed the following metrics:
Avg. Outcome Recall that a treatment regime assigns a
treatment to every subject in the population. We used the
prediction model yˆ (defined in Section 3.3) to obtain an out-
come score given the characteristics of the subject and the
treatment assigned (we used ground truth outcome scores
whenever they were available in the data). We computed
the average outcome score of all the subjects in the popula-
tion.
Avg. Assess Cost We determined assessment costs in-
curred by each subject based on what characteristics were
used to determine their treatment. We then averaged all
such per-subject assessment costs to obtain the average as-
sessment cost.
Avg. # of Characs We determined the number of charac-
teristics that are used when assigning a treatment to each
subject in the population and then computed the average of
these numbers.
Avg. Treat Cost We computed the average of the treatment
costs incurred by all the subjects in the population.
List Len Our approach CITR and the baseline IPTL ex-
press treatment regimes as decision lists. In order to com-
pare the complexity of the resulting decision lists, we com-
puted the number of rules in each of these lists.
While higher values of average outcome are preferred,
lower values on all of the other metrics are desirable.
Results Table 2 (top panel) presents the values of the
metrics computed for our approach as well as the base-
lines. It can be seen that the treatment regimes produced
by our approach results in better average outcomes with
lower costs across both datasets. While IPTL and MCA
do not explicitly reduce costs, they do minimize the num-
ber of characteristics required for determining treatment of
any given subject. Our approach produces regimes with
the least cost for a given average number of characteris-
tics required to determine treatment (Avg. # of Characs).
It is also interesting that our approach produces more con-
cise lists with fewer rules compared to the baselines. While
the treatment costs of all the baselines are similar, there is
some variation in the average assessment costs and the out-
comes. IPTL turns out to be the best performing baseline
in terms of the average outcome, average assessment costs,
and average no. of characteristics. The last line of Table
2 shows the average outcomes and the average treatment
costs computed empirically on the observational data. Both
of our datasets are comprised of decisions made by human
experts. It is interesting that the regimes learned by algo-
rithmic approaches perform better than human experts on
both of the datasets.
Bail Dataset Asthma Dataset
Avg. Avg. Avg. Avg. # of List Avg. Avg. Avg. Avg. # of List
Outcome Assess Cost Treat Cost Characs. Len Outcome Assess Cost Treat Cost Characs. Len
CITR 79.2 8.88 31.09 6.38 7 74.38 13.87 11.81 7.23 6
IPTL 77.6 14.53 35.23 8.57 9 71.88 18.58 11.83 7.87 8
MCA 73.4 19.03 35.48 12.03 - 70.32 19.53 12.01 10.23 -
OWL (Gaussian) 72.9 28 35.18 13 - 71.02 25 12.38 16 -
OWL (Linear) 71.3 28 34.23 13 - 71.02 25 12.38 16 -
CITR - No Treat 80.5 8.93 34.48 7.57 7 77.39 14.02 12.87 7.38 7
CITR - No Assess 81.3 13.83 32.02 9.86 10 78.32 18.28 12.02 8.97 9
CITR - Outcome 81.7 13.98 34.49 10.38 10 79.37 18.28 12.88 9.21 9
Human 69.37 - 33.39 - - 68.32 - 12.28 - -
Table 2: Results for Treatment Regimes. Our approach: CITR; Baselines: IPTL, MCA, OWL; Ablations of our approach:
CITR - No Treat, CITR - No Assess, CITR - Outcome; Human refers to the setting where judges and doctors assigned
treatments.
4.1.1 Ablation Study
We also analyzed the effect of various terms of our objec-
tive function on the outcomes, and the costs incurred. To
this end, we experimented with three different ablations of
our approach: 1) CITR - No Treat, which is obtained by ex-
cluding the term corresponding to the expected treatment
cost in our objective (g3(pi) in Eqn. 9). 2) CITR - No As-
sess, which is obtained by excluding the expected assess-
ment cost term in our objective (g2(pi)) in Eqn. 9) 3) CITR -
Outcome, which is obtained by excluding both assessment
and treatment cost terms from our objective.
Table 2 (second panel) shows the values of the metrics dis-
cussed earlier in this section for all the ablations of our
model. Naturally, removing the treatment cost term in-
creases the average treatment cost on both datasets. Nat-
urally, removing the assessment cost part of the objective
results in regimes with much higher assessment costs (8.88
vs. 13.83 on bail data; 13.87 vs. 18.28 on asthma data). The
length of the list also increases for both the datasets when
we exclude the assessment cost term. These results demon-
strate that each term in our objective function is crucial to
producing a cost-effective interpretable regime.
4.2 Qualitative Analysis
The treatment regimes produced by our approach on
asthma and bail datasets are shown in Figures 1 and 3 re-
spectively.
It can be seen in Figure 3 that methacholine test which is
more expensive appears at the end of the regime. This en-
sures that only a small fraction of the population (8.23%)
is burdened by its cost. Furthermore, it turns out that
though the spirometry test is slightly expensive compared
to patient demographics and symptoms, it would be harder
to determine the treatment for a patient without this test.
This aligns with research on asthma treatment recommen-
dations [27, 5]. Furthermore, it is interesting to note that
the regime not only accounts for test results on spirometry
and peak flow but also assesses if the patient has a previous
history of asthma or respiratory issues. If the test results are
positive and the patient has no previous history of asthma
or respiratory disorders, then the patient is recommended
quick relief drugs. On the other hand, if the test results are
positive and the patient suffered previous asthma or respi-
ratory issues, then controller drugs are recommended.
If Gender=F and Current-Charge =Minor Prev-Offense=None then RP
Else if Prev-Offense=Yes and Prior-Arrest =Yes then RC
Else if Current-Charge =Misdemeanor and Age≤ 30 then RC
Else if Age≥ 50 and Prior-Arrest=No, then RP
Else if Marital-Status=Single and Pays-Rent =No and Current-Charge =Misd. then RC
Else if Addresses-Past-Yr≥ 5 then RC
Else RP
Figure 3: Treatment regime for bail data; RP refers to
milder form of treatment: release on personal recogni-
zance, and RC is release on condition which is compara-
tively harsher.
In case of the bail dataset, the constructed regime is able
to achieve good outcomes without even using the most
expensive characteristics such as mental illness tests and
drug tests. Personal information characteristics, which are
slightly more expensive than defendant demographics and
prior criminal history, appear only towards the end of the
list and these checks apply only to 21.23% of the popula-
tion. It is interesting that the regime uses the defendant’s
criminal history as well as personal and demographic in-
formation to make recommendations. For instance, fe-
males with minor current charges (such as driving offenses)
and no prior criminal records are typically released on bail
without conditions such as bonds or checking in with the
police. On the other hand, defendants who have committed
crimes earlier are only granted conditional bail.
5 Conclusions
In this work, we proposed a framework for learning cost-
effective, interpretable treatment regimes from observa-
tional data. To the best of our knowledge, this is the first
solution to the problem at hand that addresses all of the fol-
lowing aspects: 1) maximizing the outcomes 2) minimiz-
ing the treatment costs, and costs associated with gathering
information required to determine the treatment 3) express-
ing regimes using an interpretable model. We modeled the
problem of learning a treatment regime as a MDP and em-
ployed a variant of UCT which prunes the search space us-
ing customized checks. We demonstrated the effectiveness
of our framework on real world data from judiciary and
health care domains.
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6 Appendix
6.1 Proof for Theorem 1
Statement: The objective defined in Eqn. 8 is NP-hard.
Proof: The rough idea behind this proof is to estab-
lish the connection between the objective in Eqn. (8) and
weighted exact-cover problem.
Our objective function is given by:
arg max
pi∈C(L)×A
λ1g1(pi)− λ2g2(pi)− λ3g3(pi) (9)
The goal is to find a sequence of (c, a) pairs where
c ∈ {FP ∪ ∅} and a ∈ A which not only covers all the
data points in the dataset but also maximizes the objective
given above. Note that c = ∅ denotes a default rule.
FP represents a set of frequently occurring patterns each
of which is a conjunction of one or more predicates.
Examples:
(1) Age ≥ 40 ∧ Gender = Female;
(2) BMI = High;
(3) Gender = M ∧ BP = High ∧ Age ≤ 25
Such patterns are provided as input to us. We have defined
the set L as: L = FP × A. This implies that an element
in the set L will be of the form:
(Age ≥ 40 ∧ Gender = Female, T1) i.e., each element in
L is a rule. Our goal is now to find an ordered list of rules
from L (let us ignore the default rule for a little while)
which maximize the objective in Eqn. 9.
Let us assume the set L comprises of the following
candidate rules:
(1) (Age ≥ 40 ∧ Gender = Female, T1)
(2) (Age ≥ 40 ∧ Gender = Female, T2)
(3) (BMI = High, T1)
(4) (BMI = High, T2)
Let us create a new set L′ from L as follows: for each
rule (c, a) in L, append the negations of conditions of
all possible combinations of all the other rules in L.
Also include in the new set L′, the set of all possible
combinations of negations of conditions in all the rules in
the set L. Following our example above, the new set L′
will look like this:
(1) (Age ≥ 40 ∧ Gender = Female, T1)
(2) (Age ≥ 40 ∧ Gender = Female, T2)
(3) (¬(Age ≥ 40 ∧ Gender = Female), T1)
(4) (¬(Age ≥ 40 ∧ Gender = Female), T2)
(5) (¬ (BMI = High) ∧ Age ≥ 40 ∧ Gender = Female,
T1)
(6) (¬ (BMI = High) ∧ Age ≥ 40 ∧ Gender = Female,
T2)
(7) (BMI = High, T1)
(8) (BMI = High, T2)
(9) (¬(BMI = High), T1)
(10) (¬(BMI = High), T2)
(11) (¬ (Age ≥ 40 ∧ Gender = Female) ∧ BMI = High,
T1)
(12) (¬ (Age ≥ 40 ∧ Gender = Female) ∧ BMI = High,
T2)
(13) (¬(Age≥ 40 ∧ Gender = Female) ∧ ¬(BMI = High),
T1)
(14) (¬(Age≥ 40 ∧ Gender = Female) ∧ ¬(BMI = High),
T2)
Now, the problem of finding an ordered sequence of rules
on L (plus a default rule a ∈ A) can now be posed as the
problem of finding an unordered set of rules on L′. To
illustrate, let us consider a decision list constructed using
L in the above example:
(1) (Age ≥ 40 ∧ Gender = Female, T1)
(2) T2
This list can now be expressed as an unordered set using
the elements in L′ as follows:
(Age ≥ 40 ∧ Gender = Female, T1)
(¬(Age ≥ 40 ∧ Gender = Female), T2)
We have thus reduced the problem of finding an ordered
list of rules to that of unordered set of rules on L′. More
specifically, the problem is now reduced to that of choos-
ing a set of rules from the set L′ such that 1) each data
point/element in the data is covered exactly once 2) the
objective function in Eqn. 9 is maximized. This problem
can be formally written as:
min
j∈L′
Ψ(j)φ(j)
s.t.
∑
j:satisfy(xi,cj)
φ(j) = 1 ∀ i : (xi, ai, yi) ∈ D
φ(j) ∈ {0, 1} ∀j : rj ∈ L′ (10)
where φ(j) is an indicator function which is 1 if the rule rj
is chosen to be in the set cover. Ψ(j) is the cost associated
with choosing the rule rj = (cj , aj) which is defined as:
Ψ(j) =
∑
i:satisfy(xi,cj)
−λ1
N
o(i, aj)+
λ2
N
∑
e∈cj
d(e)+
λ3
N
d′(aj)
Note that we basically split our complete objective func-
tion across the rules that will be chosen to be part of the
final set cover. Further, we are dealing with a minimization
problem here, so we flip the signs of the terms in the
objective (which is a maximization function).
Eqn. 10 is the weighted exact cover problem. Since this
problem is NP-Hard, our objective function is also NP-
Hard.
